An unanswered care question is a reason to pause.

A prescription step disappears

When a medicine requires a prescription, handing it over without a valid one is unlawful under federal law.

Ask who will assess you and issue any prescription. If the answer stays hidden behind the checkout, leave the decision open rather than fill the gap yourself.

Approval is stretched beyond what it means

FDA, the Food and Drug Administration, has not approved compounded medicines. Describing them as FDA-approved is incorrect.

A maker’s FDA registration records the medicine-making site with the agency. An offer may also show a product’s number in FDA’s drug directory, a government list. Neither gives the medicine FDA approval.

Ask which exact approved product is being named, or whether the offer is for a compounded preparation. Keep that answer beside the ingredient name.

The label names a pharmacy you cannot confirm

FDA has seen compounded weight-medicine labels naming nonexistent pharmacies, including on semaglutide and tirzepatide products.

FDA’s online-pharmacy checks flag damaged packs, missing use instructions and no pharmacist available for questions.

FDA notes that fake pharmacy storefronts can make an unsafe operation look licensed.

Contact the named pharmacy through details you can confirm from its own licensing record. Ask it to resolve the mismatch before treating the label as an answer.

A research label is offered as reassurance

FDA says that products marketed as “for research purposes” for people to use can have unknown quality and may harm health.

Keep treatment questions with a clinician and a dispensing pharmacy. A research label cannot explain how a product meets your care needs.